LAMISIL cpr 250 mg 28 pce
7680513060239
Pharmacode 1434597
CH-51306
D01BA02
08.06.0.
Fiches Amavita / Sun Store / Coop Vitality
Details
- GTIN
- 7680513060239
- Pharmacode
- 1434597
- Product number
- 5130602
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- terbinafinum 250 mg ut terbinafini hydrochloridum, magnesii stearas, hypromellosum, silica colloidalis anhydrica, carboxymethylamylum natricum A corresp. natrium max. 1.9 mg, cellulosum microcristallinum pro compresso.
Articles (1)
Lamisil 250 mg, Tabletten
Tabletten
28
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
terbinafinum
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
terbinafini hydrochloridum
|
- | Substance | WIZUS |
|
magnesii stearas
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
carboxymethylamylum natricum A
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 51306
- Drug name
- Lamisil, Tabletten
- Galenic form
- TAB
- ATC Code
- D01BA02
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 27/08/1991
- Authorization expiration date
- 03/09/2026
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LAMISIL cpr 250 mg 28 pce
- Description (DE)
- LAMISIL Tabl 250 mg 28 Stk
- Market launch
- 27/08/1991
- Market withdrawal
- 30/06/2026
- Narcotic (BTM)
- No